1) eplerenone
依普利酮
1.
Improved synthesis of canrenone, the intermediate of eplerenone;
依普利酮中间体坎利酮的合成工艺改进
2.
Effects of Eplerenone on Myocardium Fibrosis in Guanylyl Cyclase-A knockout Mice;
依普利酮对鸟苷酸环化酶偶联受体A基因敲除小鼠心肌纤维化的作用
3.
A Systematic Review of Eplerenone for Essential Hypertension;
依普利酮治疗原发性高血压有效性和安全性的系统评价
2) intermediate of eplerenon
依普利酮中间体
3) Ipriflavone
依普黄酮
1.
Effects of Different Concentrations of Tween-80 on Dissolution of Ipriflavone Capsules;
吐温-80不同浓度对依普黄酮胶囊溶出度的影响
2.
Preparation and determination of ipriflavone capsules;
依普黄酮胶囊的制备及含量测定
3.
Determination of ipriflavone metabolism in rat hepatic microsomes by RP-HPLC;
反相高效液相色谱法测定鼠肝微粒体中依普黄酮及其在代谢研究中的应用
4) eprazinone
依普拉酮
5) enalapril
依那普利
1.
Research and market development of enalapril;
依那普利研发及市场概况
2.
Effect of Enalapril on paroxysmal atrial fibrillation in patients with essential hypertension;
依那普利治疗高血压并阵发性房颤的超声改变和疗效
3.
Clinical Effects of Enalapril Combined with Valsartan for Chronic Heart Failure;
依那普利联合缬沙坦治疗慢性心力衰竭的临床观察
6) Enapril
依那普利
1.
Treatments of combined with medication of netrilix and enapril on heart failure induced by hypertensive heart disease;
钠催离及依那普利联用治疗高血压性心脏病心力衰竭
2.
The effect of Enapril on glomerular extracellular matrix accumulation in rats with 5/6 renal mass ablation;
依那普利对大鼠残肾细胞外基质蓄积的作用观察
3.
Enapril 10 mg/d was taken by 38 subjects in control group, 40 subjects in treatment group were administered with enapril 10 mg/d and atorvastatin 20 mg/d orally.
目的观察阿托伐汀联用依那普利对老年单纯收缩期高血压患者血压的影响。
补充资料：依普利酮
分子式：C24H30O6
分子量：414.49
CAS号：107724-20-9
性质：
分子量：414.49
CAS号：107724-20-9
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条